MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR TAG3 OR T1G3 AND/OR CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMISED CUETO GROUP STUDY | Publicación